ANFI shares have been hammered down by the short seller (see ANFI analysis article on SeekingAlpha) since Mid August 2015.
However, the company later denied all "false?" claims regarding to that short article.
Interesting enough, someone recently posted a LONG article.
seekingalpha.com
It seems reasonable to me (I used to have ANFI in my portfolio 2...
HZNP, a strong growth specialty biopharmaceutical company, Its shares have been in a down trend lately which could blame the overall weakness in the market and the action between the firm and DEPO which is their target of acquisition.
I personally like HZNP due to its pipeline and strong growth. The latest quarterly earning showed that its growth was accelerated....
I found INBK through a Bloomberg terminal screening by using YoY growth in both EPS and Revenue ( >= +20%) then I sorted the list by the YTD return.
By just looking at the YTD return, INBK made a nice run for this year.
Their earning has been increasing since last year and that's why I think INBK performed really well lately.
Nonetheless, it may be a good...
Trying to apply what I learn from IBD's CANSLIM
On their IBD website, CUBI is the group leader (followed by SBNY - my favorite stock)
The recent rally did not have a nice base pattern (I might be wrong).
I might just wait for any pull back to 10W MA or 50D MA for LONG entry.
I heard from my friend that they won from the stock pitch competition by pitching FL.
I am one of FL's loyal customer ... However, I've never thought that this stock made an OK run lately.
Anyway, as a growth seeker, I felt like FL's growth on Earning and sales are not as high as I would like to really go LONG on it. Though, it might be high enough and...
